[HTML][HTML] Novel biomarkers for the management of chronic hepatitis B
T Inoue, Y Tanaka - Clinical and molecular hepatology, 2020 - ncbi.nlm.nih.gov
Hepatitis B virus (HBV) cannot be eliminated completely from infected hepatocytes because
of the presence of intrahepatic covalently closed circular DNA (cccDNA). As chronic hepatitis …
of the presence of intrahepatic covalently closed circular DNA (cccDNA). As chronic hepatitis …
Tumor markers for hepatocellular carcinoma
YJ Zhao, Q Ju, GC Li - Molecular and clinical oncology, 2013 - spandidos-publications.com
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors with a high
rate of morbidity and mortality. HCC affects approximately one million individuals annually …
rate of morbidity and mortality. HCC affects approximately one million individuals annually …
[HTML][HTML] AFP-L3 for the diagnosis of early hepatocellular carcinoma: A meta-analysis
JM Zhou, T Wang, KH Zhang - Medicine, 2021 - journals.lww.com
Background: The present study aimed to systematically evaluate the diagnostic value of an
isoform of alpha-fetoprotein (AFP), AFP-L3, for early hepatocellular carcinoma (HCC) by a …
isoform of alpha-fetoprotein (AFP), AFP-L3, for early hepatocellular carcinoma (HCC) by a …
Updating the clinical application of blood biomarkers and their algorithms in the diagnosis and surveillance of hepatocellular carcinoma: a critical review
The most common primary liver cancer is hepatocellular carcinoma (HCC), and its mortality
rate is increasing globally. The overall 5-year survival of patients with liver cancer is …
rate is increasing globally. The overall 5-year survival of patients with liver cancer is …
Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy
W Ma, H Wang, L Teng - World journal of surgical oncology, 2013 - Springer
Background To investigate the prediction value of preoperative serum alpha-fetoprotein
(AFP) level for the prognosis of hepatocellular carcinoma (HCC), by comparing pathological …
(AFP) level for the prognosis of hepatocellular carcinoma (HCC), by comparing pathological …
Biomarkers for the early detection of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, and
the cancer with the fastest increase in mortality in the United States, with more than 39,000 …
the cancer with the fastest increase in mortality in the United States, with more than 39,000 …
Mitochondrial ROS driven by NOX4 upregulation promotes hepatocellular carcinoma cell survival after incomplete radiofrequency ablation by inducing of mitophagy …
C Peng, X Li, F Ao, T Li, J Guo, J Liu, X Zhang… - Journal of Translational …, 2023 - Springer
Background The recurrence of hepatocellular carcinoma (HCC) after radiofrequency
ablation (RFA) remains a major clinical problem. Cells that survive the sublethal heat stress …
ablation (RFA) remains a major clinical problem. Cells that survive the sublethal heat stress …
The GALAD scoring algorithm based on AFP, AFP-L3, and DCP significantly improves detection of BCLC early stage hepatocellular carcinoma
J Best, H Bilgi, D Heider, C Schotten… - Zeitschrift für …, 2016 - thieme-connect.com
Background: Hepatocellular carcinoma (HCC) is one of the leading causes of death in
cirrhotic patients worldwide. The detection rate for early stage HCC remains low despite …
cirrhotic patients worldwide. The detection rate for early stage HCC remains low despite …
Fucosylation in cancer biology and its clinical applications
M Shan, D Yang, H Dou, L Zhang - Progress in molecular biology and …, 2019 - Elsevier
Fucosylation is the process of transferring fucose from GDP-fucose to their substrates, which
includes certain proteins, N-and O-linked glycans in glycoprotein or glycolipids, by …
includes certain proteins, N-and O-linked glycans in glycoprotein or glycolipids, by …
[HTML][HTML] The diagnosis and treatment of hepatocellular carcinoma
NP Malek, S Schmidt, P Huber, MP Manns… - Deutsches Ärzteblatt …, 2014 - ncbi.nlm.nih.gov
Background The incidence of hepatocellular carcinoma (HCC) has continued to rise in
recent years. This increase has been attributed to alcohol-induced liver diseases, metabolic …
recent years. This increase has been attributed to alcohol-induced liver diseases, metabolic …